Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of Parageobacillus Bacteriophage vB_PtoS_NIIg3.2-A Representative of a New Genus within Thermophilic Siphoviruses. | Int J Mol Sci | 2023 | 37762288 | PubTator, text mining | PubMed |
| Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects. | Future Sci OA | 2023 | 37752917 | PubTator, text mining | PubMed |
| FGFR families: biological functions and therapeutic interventions in tumors. | MedComm (2020) | 2023 | 37750089 | PubTator, text mining | PubMed |
| Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions. | MedComm (2020) | 2023 | 37719443 | PubTator, text mining | PubMed |
| Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2023 | 37685904 | PubTator, text mining | PubMed |
| Integrins and Actions of Androgen in Breast Cancer. | Cells | 2023 | 37681860 | PubTator, text mining | PubMed |
| Differences between migrasome, a 'new organelle', and exosome. | J Cell Mol Med | 2023 | 37665060 | PubTator, text mining | PubMed |
| The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer. | Front Bioeng Biotechnol | 2023 | 37662434 | PubTator, text mining | PubMed |
| Diagnostic implications of pitfalls in causal variant identification based on 4577 molecularly characterized families. | Nat Commun | 2023 | 37644014 | PubTator, text mining | PubMed |
| Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts. | J Exp Clin Cancer Res | 2023 | 37641132 | PubTator, text mining | PubMed |
| Systematic investigation of the homology sequences around the human fusion gene breakpoints in pan-cancer - bioinformatics study for a potential link to MMEJ. | Brief Bioinform | 2023 | 37635381 | PubTator, text mining | PubMed |
| Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. | Int J Mol Sci | 2023 | 37629204 | PubTator, text mining | PubMed |
| Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37626362 | PubTator, text mining | PubMed |
| Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts. | BMC Nephrol | 2023 | 37626301 | PubTator, text mining | PubMed |
| Biogenesis, Isolation, and Detection of Exosomes and Their Potential in Therapeutics and Diagnostics. | Biosensors (Basel) | 2023 | 37622888 | PubTator, text mining | PubMed |
| Imaging and quantitative analysis of integrin-dependent cell-matrix adhesions. | STAR Protoc | 2023 | 37616164 | PubTator, text mining | PubMed |
| Comprehensive cell surface protein profiling of human mesenchymal stromal cells from peritoneal dialysis effluent and comparison with those from human bone marrow and adipose tissue. | Hum Cell | 2023 | 37603218 | PubTator, text mining | PubMed |
| Hydrogen-rich saline alleviates cardiomyocyte apoptosis by reducing expression of calpain1 via miR-124-3p. | ESC Heart Fail | 2023 | 37602925 | PubTator, text mining | PubMed |
| [Corrigendum] The tetraspanin CD151‑ARSA mutant inhibits angiogenesis via the YRSL sequence. | Mol Med Rep | 2023 | 37594051 | PubTator, text mining | PubMed |
| Modeling and optimization of parallelized immunomagnetic nanopore sorting for surface marker specific isolation of extracellular vesicles from complex media. | Sci Rep | 2023 | 37587235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=9